Skip to the main content

Meeting abstract

https://doi.org/10.15836/ccar2024.399

Pulsed field ablation-guided cardioneuroablation – experience from the University Hospital Centre Split

Lucija Lisica Kordić orcid id orcid.org/0000-0003-1904-0259 ; University Hospital Centre Split, Split Croatia
Ivan Sikirić orcid id orcid.org/0000-0003-4913-1346 ; University Hospital Centre Split, Split Croatia
Zrinka Jurišić orcid id orcid.org/0000-0001-7583-9036 ; University Hospital Centre Split, Split Croatia
Ante Anić orcid id orcid.org/0000-0002-6864-3999 ; University Hospital Centre Split, Split Croatia
Toni Brešković orcid id orcid.org/0000-0001-7266-2087 ; University Hospital Centre Split, Split Croatia


Full text: english pdf 475 Kb

page 399-400

downloads: 207

cite

Download JATS file


Abstract

Keywords

cardioneuroablation; pulsed field ablation; vagal denervation; syncope

Hrčak ID:

327825

URI

https://hrcak.srce.hr/327825

Publication date:

13.12.2024.

Visits: 555 *



Introduction: Endocardial vagal denervation, known as cardioneuroablation (CNA), is an emerging treatment option for treating conditions associated with symptomatic periods of increased vagal tone such as refractory vasovagal syncope (VVS), functional atrioventricular block, and sinus node dysfunction (SND) (1). The cornerstone of CNA is targeting groups of autonomic ganglia known as ganglionated plexi (GP) (1). Pulsed field ablation (PFA) is a non-thermal form of energy during which a strong electric field delivered to the underlying tissue leads to the opening of pores on the cell membrane, resulting in the destruction of the cell (2).

Patients and Methods: Cardioneuroablation was performed in symptomatic patients with proven cardioinhibitory reflex. The procedure was performed in deep sedation with propofol, fentanyl and midazolam. Standard transseptal approach was obtained and 3D electroanatomical mapping of the left atrium was preformed prior to the ablation. The presumed anatomical location of the right superior vagal GP was verified by the delivery of focal PFA lesion in anterosuperior aspect of right superior pulmonary vein ostium. The proximity to the ganglion was verified by the induction of transitory sinus bradycardia after PFA delivery. Once the anatomical position was verified, further ablation was performed using radiofrequency energy. Additional consolidation lesions were applied from the right side of interatrial septum. The ablation was considered successful by the lack of vagal response after repeated PFA delivery at the initial position (Figure 1) (3).

FIGURE 1 An example of the use of pulse field ablation (PFA)-guided cardioneuroablation (CNA) in one patient. Panel A: application of PFA (yellow dot) to the anterior superior ostium of the right superior pulmonary vein causes transient sinus bradycardia, indicating proximity to the right superior vagal ganglion. Panel B: set of radiofrequency ablation lesions surrounding the initial PFA application site. Panel C: after ablation, application of PFA does not induce sinus bradycardia.
CC202419_11-12_399-400-f1

Results: The PFA-guided CNA was performed in 4 patients. In 2 the indication was SND and in other 2 VVS. Acute endpoint was obtained in all patients. During the median follow up period of 12 months all patients remained symptom free (Table 1).

TABLE 1 Cohort of patients treated with cardioneuroablation guided by pulsed field ablation at University Hospital Centre Split.
Pt.SexAgeIndicationFollow up period (months)Recurrence
001F35Sinus arrest14NO
002F40Vasovagal syncope12NO
003M42Vasovagal syncope12NO
004M44Sinus arrest1NO

Conclusion: A PFA-guided CNA is a safe procedure with promising acute success rate and could be the treatment option for patients with pronounced drug-refractory cardioinhibitory reflex. Larger randomized studies are warranted to assess the procedural success rate and further optimize ablation strategy.

LITERATURE

1 

Pachon JC, Pachon EI, Aksu T, Gopinathannair R, Kautzner J, Yao Y, et al. Cardioneuroablation: Where are we at? Heart Rhythm O2. 2023 March 21;4(6):401–13. https://doi.org/10.1016/j.hroo.2023.02.007 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/37361615

2 

Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005 February;33(2):223–31. https://doi.org/10.1007/s10439-005-8981-8 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/15771276

3 

Sikiric I, Jurisic Z, Breskovic T, Juric-Paic M, Berovic N, Kedzo J, et al. Focal pulsed field ablation for guiding and assessing the acute effect of cardioneuroablation. J Interv Card Electrophysiol. 2024 January 29; https://doi.org/10.1007/s10840-023-01716-4 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/38285282


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.